Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline
書誌事項
- 公開日
- 2018-06
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- https://www.elsevier.com/legal/tdmrep-license
- http://creativecommons.org/licenses/by-nc-nd/4.0/
- DOI
-
- 10.1016/j.jcyt.2018.03.032
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- Cytotherapy
-
Cytotherapy 20 (6), 806-819, 2018-06
Elsevier BV